Detalles de la búsqueda
1.
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant.
Health Qual Life Outcomes
; 21(1): 40, 2023 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37158911
2.
Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression.
Int J Neuropsychopharmacol
; 25(4): 269-279, 2022 04 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022754
3.
Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study.
Am J Geriatr Psychiatry
; 30(5): 541-556, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34750057
4.
Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials.
Arch Womens Ment Health
; 25(2): 313-326, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973081
5.
A Choice-Based Conjoint Analysis of the Psychiatrist Decision-Making Process Used in Determining When to Discharge Adults With Major Depressive Disorder Hospitalized for Active Suicidal Ideation With Intent.
J Nerv Ment Dis
; 210(5): 373-379, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34937847
6.
Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression.
Acta Psychiatr Scand
; 143(3): 253-263, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249552
7.
The effect of esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder.
Depress Anxiety
; 38(11): 1120-1130, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34293233
8.
Association of depression symptom severity with short-term risk of an initial hospital encounter in adults with major depressive disorder.
BMC Psychiatry
; 21(1): 257, 2021 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34001045
9.
Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.
Int J Neuropsychopharmacol
; 23(7): 426-433, 2020 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32270176
10.
Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3.
Am J Geriatr Psychiatry
; 28(2): 121-141, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31734084
11.
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Int J Neuropsychopharmacol
; 22(10): 616-630, 2019 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31290965
12.
Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.
Mol Psychiatry
; 27(4): 1860-1862, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35177823
13.
Comments to Drs. Gastaldon, Raschi, Kane, Barbui, and Schoretsanitis.
Psychother Psychosom
; 90(2): 138-139, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33108791
14.
Metabolic and body mass parameters after treatment with JNJ-37822681, a novel fast-dissociating D2 receptor antagonist, vs olanzapine in patients with schizophrenia.
Ann Clin Psychiatry
; 25(3): 173-83, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23926573
15.
Post-Approval Research in Drug Development: Priorities and Practices.
Adv Neurobiol
; 30: 169-180, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36928849
16.
Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability.
J Affect Disord
; 321: 153-160, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273682
17.
Climate Change Helps Polar Invasives Establish and Flourish: Evidence from Long-Term Monitoring of the Blowfly Calliphora vicina.
Biology (Basel)
; 12(1)2023 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36671803
18.
Suicide-specific mortality among patients with treatment-resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone.
Brain Behav
; 13(8): e3171, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37475597
19.
Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray.
Psychiatry Res
; 323: 115165, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37019044
20.
What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?
Depress Anxiety
; 29(2): 94-101, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22147631